Vimarsana
Biggest News Aggregation in the World

Adam Plich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adam Plich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adam Plich Today - Breaking & Trending Today

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries - Vimarsana News

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries

AMSTERDAM, October 18, 2023--Avanzanite's expanded collaboration with Advicenne now includes Ireland, Cyprus and Malta in addition to existing markets (DE, AT, CH, GR, LI).

Source: yahoo.com
Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany - Vimarsana News

Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany

AMSTERDAM--(BUSINESS WIRE)--Sep 19, 2023--

Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece - Vimarsana News

Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece

Avanzanite Bioscience B.V. (“Avanzanite” or the “Company”), a specialty pharmaceutical company offering end-to-end commercialization and distribution partnerships with research-based biopharmaceutical originators, announced today that it has signed an exclusive distribution agreement with Paris-based specialty ...

Avanzanite Bioscience B.V.: Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece - Vimarsana News

Avanzanite Bioscience B.V.: Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece

Advicenne agreement further validates Avanzanite's unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across Europe Avanzanite

Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and - Vimarsana News

Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and

Advicenne agreement further validates Avanzanite’s unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across EuropeAvanzanite now transitioning to sales execution with the first anticipated commercial launch in Germany mid 2023 AMSTERDAM--(...